SARAH ALLAN: Open Payments
NPI 1245871623 · FARMINGTON, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 9 payments from 8 companies in 2025. Trend: 2023 $466 · 2024 $202 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $110 |
| E.R. Squibb & Sons, L.L.C. | 1 | $53 |
| ABBVIE INC. | 1 | $24 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $22 |
| GENZYME CORPORATION | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: Rhapsido, Sotyktu, RINVOQ, Cabtreo, DUPIXENT, TALTZ, OTEZLA, NEMLUVIO.
Industry payments across NM — which companies pay providers there.
